The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample

Lithium Treatment Moderate-Dose Use Study (LiTMUS) for Bipolar Disorder: A Randomized Comparative Effectiveness Trial of Optimized Personalized Treatment With and Without Lithium

(2013) Andrew A. Nierenberg et al.   AMERICAN JOURNAL OF PSYCHIATRY

Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry

(2012) Konstantinos N. Fountoulakis et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative

(2011) Kathleen R. Merikangas et al.   ARCHIVES OF GENERAL PSYCHIATRY

State of the Art: Treatment of Bipolar Disorders

(2011) Emanuel Severus et al.   CNS Neuroscience & Therapeutics

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial

(2010)   LANCET

A Genomewide Association Study of Response to Lithium for Prevention of Recurrence in Bipolar Disorder

(2009) Roy H. Perlis et al.   AMERICAN JOURNAL OF PSYCHIATRY

MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment

(2009) Haiming Chen et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Prédicteurs de réponse prophylactique au lithium

(2008) J. Rohayem et al.   ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE

Evidence for Selective microRNAs and Their Effectors as Common Long-Term Targets for the Actions of Mood Stabilizers

(2008) Rulun Zhou et al.   NEUROPSYCHOPHARMACOLOGY

Deciphering the lithium transcriptome: Microarray profiling of lithium-modulated gene expression in human neuronal cells

(2007) R.S. Seelan et al.   NEUROSCIENCE